Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors (Q36690209)
Jump to navigation
Jump to search
scientific article published on 8 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors |
scientific article published on 8 March 2013 |
Statements
1 reference
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors (English)
1 reference
Claudia Marcela Diaz
1 reference
Alberto Chiappori
1 reference
Luigi Aurisicchio
1 reference
Ansuman Bagchi
1 reference
Jason Clark
1 reference
Sheri Dubey
1 reference
Arthur Fridman
1 reference
Jesus C Fabregas
1 reference
John Marshall
1 reference
Elisa Scarselli
1 reference
Nicola La Monica
1 reference
Gennaro Ciliberto
1 reference
Alberto J Montero
1 reference
8 March 2013
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference
Sitelinks
Wikipedia(0 entries)
Wikibooks(0 entries)
Wikinews(0 entries)
Wikiquote(0 entries)
Wikisource(0 entries)
Wikiversity(0 entries)
Wikivoyage(0 entries)
Wiktionary(0 entries)
Multilingual sites(0 entries)
